Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy
NCT00188500 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-12-29
Summary
The purpose of this study is to determine whether patients with uncontrolled epilepsy can follow a low carbohydrate diet long-term and if so, how will that diet affect their seizures
Conditions
Interventions
- BEHAVIORAL
-
atkins diet
- BEHAVIORAL
-
ability to follow low carbohydrate diet
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Principal Investigators
-
J Martin delCampo · UHN
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Completion
- 2005-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
NCT03183076 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
NCT01906398 ·Status: UNKNOWN ·Phase: PHASE2
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Ketogenic Diet in Pediatric Intractable Epilepsy
NCT06310954 ·Status: RECRUITING ·Phase: NA
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet
NCT05898438 ·Status: UNKNOWN
-
Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study
NCT05958160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues
NCT02565966 ·Status: COMPLETED ·Phase: NA
-
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
NCT00280059 ·Status: COMPLETED ·Phase: PHASE3
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
NCT00866775 ·Status: COMPLETED ·Phase: PHASE3
-
Conversion to Monotherapy Study With Keppra XR for Partial Seizures
NCT00419094 ·Status: COMPLETED ·Phase: PHASE3
-
Epigenetics and Gut Microbiota in Children With Epilepsy
NCT04063007 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00150293 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
NCT00961441 ·Status: COMPLETED ·Phase: PHASE2
-
Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures
NCT05219006 ·Status: COMPLETED ·Phase: NA
-
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
NCT00143143 ·Status: COMPLETED ·Phase: PHASE3
-
Role of the Gut Microbiota in Pediatric Epilepsy
NCT04705298 ·Status: UNKNOWN ·Phase: PHASE4
-
Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
NCT00596466 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR
NCT00368069 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
NCT00141414 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures
NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
NCT00524030 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Low Glycemic Index Diet Versus Classic Ketogenic Diet in Pediatric Epilepsy Treatment
NCT06703983 ·Status: COMPLETED ·Phase: NA